TrademarkDir
CLEREZO
LIVE

Serial Number

79100187

Owner

ThromboGenics NV

Filing Date

May 18, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CLEREZO Trademark

Serial Number: 79100187 • Registration: 4137469

CLEREZO is a trademark filed by ThromboGenics NV on May 18, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ThromboGenics NV (13 trademarks)

Gaston Geenslaan 1
Heverlee 3001 , BE

Entity Type: 99

Oxurion NV (10 trademarks)

Gaston Geenslaan 1

Entity Type: 32

Trademark Details

Filing Date

May 18, 2011

Registration Date

May 8, 2012

Published for Opposition

February 21, 2012

Cancellation Date

May 18, 2021

Goods & Services

Pharmaceutical preparations and substances for the treatment or prevention of cancer, diabetes, blood disorders and cardiovascular diseases; sanitary preparations for medical purposes; medicines for human purposes, namely, for treating or preventing oncological disorders and diseases, diabetes, gastrointestinal disease, blood disorders, and cardiovascular diseases, ophthalmic medicines and surgical fluids; pharmaceutical preparations, substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical eye drops

Chemical preparations and substances for use in the manufacture of pharmaceutical products and medicines

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 12, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 12, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 4, 2019 INTS
INVALIDATION PROCESSED
Sep 4, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 14, 2019 INTR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 13, 2019 ADCH
CANCELLED SECTION 71
Dec 14, 2018 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Sep 28, 2018 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 4, 2013 NREP
NOTIFICATION PROCESSED BY IB
Nov 25, 2012 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 18, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 22, 2012 FICS
FINAL DISPOSITION PROCESSED
Oct 22, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 8, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
May 8, 2012 R.PR
PUBLISHED FOR OPPOSITION
Feb 21, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 8, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 8, 2012 OP2R
NOTICE OF PUBLICATION
Feb 1, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 17, 2012 PREV
ASSIGNED TO LIE
Jan 14, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2011 TROA
ASSIGNED TO EXAMINER
Dec 8, 2011 DOCK
REFUSAL PROCESSED BY IB
Sep 24, 2011 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2011 RFCS
REFUSAL PROCESSED BY MPU
Sep 6, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2011 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2011 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2011 REPR

Related Trademarks

More from this Owner

OXURION

OXURION

JETREA CARE

JETREA CARE

JETREA CARE

JETREA CARE

JETREA CARE

JETREA CARE

CARE logo

CARE

CARE COLLABORATION IN ACCESS & REIMBURSEMENT ESSENTIALS logo

CARE COLLABORATION IN ACCESS & REIMBURSEMENT ESSENTIALS